Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | AXSM | JANX | ||
| Company | Ultragenyx Pharmaceu | Axsome Thera | Janux Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.88 | 75.57 | 63.98 | ||
| High | 46.01 | 76.32 | 65.60 | ||
| Low | 42.67 | 74.36 | 59.31 | ||
| Last | 42.75 | 74.80 | 64.78 | ||
| Change | -0.45 | +0.61 | +2.35 | ||
| % Change | -1.04% | +0.82% | +3.76% | ||
| Volume | 1,143,000 | 767,600 | 1,049,900 | ||
| 20-Day Average Volume | 794,530 | 550,850 | 1,030,875 | ||
| Previous Close | 43.20 | 74.19 | 62.43 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 45.11 | 71.34 | 50.68 | ||
| 20-Day Raw Stochastic | 14.62% | 85.40% | 97.33% | ||
| 20-Day Relative Strength | 42.10% | 51.24% | 77.64% | ||
| Weighted Alpha | -7.85 | +0.55 | -9.52 | ||
| Today's Opinion | 8% Sell | 16% Sell | 100% Buy | ||
| Previous Opinion | 8% Sell | 64% Sell | 100% Buy | ||
| Last Month's Opinion | 40% Buy | 40% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.37% since 04/26/24 | +4.31% since 04/26/24 | +36.70% since 04/26/24 | ||
| Low | 42.24 on 05/01/24 | 73.02 on 04/30/24 | 47.58 on 04/29/24 | ||
| High | 46.01 on 05/03/24 | 76.39 on 05/01/24 | 65.60 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -9.20% since 04/03/24 | +1.77% since 04/03/24 | +78.26% since 04/03/24 | ||
| Low | 41.07 on 04/19/24 | 65.50 on 04/19/24 | 34.63 on 04/05/24 | ||
| High | 52.56 on 04/11/24 | 76.39 on 05/01/24 | 65.60 on 05/03/24 | ||
| 3-Month | |||||
| %Chg | -0.63% since 02/02/24 | -19.41% since 02/02/24 | +678.61% since 02/02/24 | ||
| Low | 41.07 on 04/19/24 | 65.50 on 04/19/24 | 7.79 on 02/05/24 | ||
| High | 54.56 on 03/01/24 | 98.40 on 02/12/24 | 65.60 on 05/03/24 | ||
| 6-Month | |||||
| %Chg | +10.10% since 11/03/23 | +14.83% since 11/03/23 | +856.87% since 11/03/23 | ||
| Low | 34.06 on 11/13/23 | 55.02 on 11/13/23 | 5.65 on 11/10/23 | ||
| High | 54.56 on 03/01/24 | 98.40 on 02/12/24 | 65.60 on 05/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,552,269 | 3,552,477 | 3,358,908 | ||
| Shares Outstanding, K | 83,094 | 47,493 | 51,851 | ||
| Annual Sales | 434,250,000 | 270,600,000 | 8,080,000 | ||
| Annual Net Income | -606,640,000 | -239,240,000 | -58,290,000 | ||
| Last Quarter Sales | 127,390,000 | 71,530,000 | 2,460,000 | ||
| Last Quarter Net Income | -123,190,000 | -98,650,000 | -11,760,000 | ||
| 60-Month Beta | 0.68 | 1.13 | 3.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.03 on 05/02/24 | -0.73 on 02/20/24 | -0.25 on 03/08/24 | ||
| Latest Earnings Date | 05/02/24 | 05/06/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||